Hormone Pellets in Houston, with the full conversation they deserve.
Hormone pellets are one of several bioidentical hormone delivery methods. We offer pellets when they're the right fit for a specific patient — and we explain honestly when another delivery method makes more sense.
Hormone pellets, explained.
Hormone pellets are small compressed cylinders — typically the size of a grain of rice — containing bioidentical testosterone (for men or women) or testosterone plus estradiol (for women). They’re inserted subcutaneously in a brief in-office procedure, usually in the upper buttock, where they release hormone continuously as they dissolve. A typical placement lasts 3–4 months in women and 4–6 months in men.
Pellets have been used clinically since the 1930s. Modern branded systems like BioTE, EvexiPEL, and SottoPelle have refined the approach with standardized dosing protocols and training programs for prescribing clinicians. The appeal is real: no daily creams, no weekly injections, no remembering anything. For specific patients, that convenience matters a lot.
At The Tide, we offer pellet therapy when it’s the right fit for a specific patient — and we recommend other delivery methods when it isn’t. This page walks through both sides honestly: how pellets work, what the tradeoffs are, and how we think through the decision with each patient during consultation. For our default approach to men’s TRT and women’s HRT, see those pages.
The mechanics of pellet therapy, plainly.
Understanding how pellets release hormone — and what that means for dosing and monitoring — is the foundation of the decision. Here’s the clinical picture.
Continuous release for months
Once placed, pellets release hormone steadily as they dissolve — typically with a higher release rate in the first 4–6 weeks, gradually declining over the following months. Many patients describe this as feeling great early in the cycle and noticing diminished effect by the final month or two before replacement.
What this means: Predictable timing · Non-uniform levelsLevels above and below physiologic range
The release curve typically produces peak levels in the first weeks that are above the high end of normal range, then declines toward (or below) the bottom of normal range before replacement. This is part of how pellets achieve their long duration. Some patients tolerate this pattern well; others find the variation noticeable.
What this means: Long duration · Variable levels through cycleDose is set at placement, not in between
Once a pellet is placed, the dose can’t be reduced or removed easily until it’s absorbed. If a patient develops side effects mid-cycle — elevated hematocrit in men, breast tenderness in women, mood changes — the management approach is supportive care while waiting for the pellet to absorb. Pellet selection at placement is therefore where most of the dose decision actually happens.
What this means: Set-and-monitor · Less in-cycle flexibilityThe mechanics aren’t problems — they’re characteristics. For some patients, the long duration and steady (if not perfectly even) delivery is exactly the right fit. For others, the inability to adjust mid-cycle is a meaningful drawback. The decision is patient-specific, and that’s what consultation is for. Compare with TRT and HRT approaches that allow more frequent dose adjustment.
How we think through pellets with each patient.
The right delivery method depends on your specific situation, history, and what you’re trying to accomplish. Here’s the conversation we’d have with you during consultation — the same one we have with every patient considering pellet therapy.
The factors that shape the decision.
For most patients, an adjustable delivery method (injection or transdermal) is the right starting point — easier to titrate, easier to adjust if your body responds unexpectedly. For some patients, the case for pellets is genuinely strong from the outset. Here’s how we evaluate.
- Are you new to hormone therapy, or have you been stable on a regimen for years?
- Do you have practical constraints that make weekly injections or daily transdermals difficult?
- What’s your baseline hematocrit, blood pressure, and cardiovascular picture?
- How important is fine-tuned dose control to your specific goals?
- Have you tried pellets before, and how did your body respond?
From consultation to placement (or alternative), in real medicine.
Whether you end up on pellets or an alternative delivery method, the workup is the same. The decision about delivery comes after we understand your specific situation — not before.
Initial consultation
In person at our Houston clinic. We discuss your symptoms, medical history, what you’ve tried before, current medications, and your goals. We explain how pellets work alongside the other delivery methods we offer and walk through the tradeoffs honestly.
Comprehensive lab work
A full hormone panel at LabCorp or Quest near you — testosterone (total and free), estradiol, SHBG, hematocrit, PSA (men over 40), thyroid, lipids, A1c, and inflammatory markers. The same workup applies whether we end up recommending pellets, injection, or transdermal.
Delivery decision together
Your physician reviews your labs and we have the delivery method conversation explicitly. If pellets fit your situation, we plan placement. If an adjustable method (injection or transdermal) is the better starting point, we explain why and design that protocol. Either way, the reasoning is documented and shared with you.
First treatment
If pellets: in-office placement procedure, typically 15–20 minutes with local anesthetic. If injection or transdermal: prescription filled at retail or compounding pharmacy with training and clear protocol guidance. Clear expectations about timeline to symptom relief in either case.
Monitor & adjust
Follow-up labs at 6 weeks after first treatment, then at 12 weeks, then quarterly. For pellets: lab timing matters — we check during the steady-release portion of the cycle, not at peak. For adjustable methods: we titrate based on labs and symptoms. The monitoring schedule is what makes either approach safe over the long term.
Considering pellets? Let’s talk it through.
A 45-minute consultation with one of our physicians. We’ll walk through how pellets compare to other delivery methods for your specific situation, and decide together what fits best — pellets, injection, transdermal, or another approach.
Patient situations where pellets do — and don’t — make sense.
The decision about pellets vs. adjustable delivery methods is patient-specific. Here are the patterns we see during consultation that tend to point one way or the other. None of this is absolute — it’s how we think through the conversation.
Pellets often make sense for
- Patients who’ve been on pellets for years, are stable, monitored on schedule, and don’t want to switch delivery methods
- Patients with significant practical constraints — severe needle phobia preventing self-injection, frequent travel, no consistent routine access to compounding pharmacy
- Patients on stable, well-established maintenance doses where the dose-release curve is well-understood for them specifically
- Patients who’ve tried adjustable methods and found the daily/weekly routine genuinely unworkable
- Patients who specifically prioritize the convenience tradeoff after understanding the full picture
Adjustable methods usually make more sense for
- Patients new to hormone therapy where initial dose response is unpredictable
- Patients with elevated baseline hematocrit or cardiovascular risk factors that benefit from rapid dose adjustment
- Women in perimenopause where hormonal needs shift month to month
- Patients who’ve had unusual responses to past hormone therapy
- Patients seeking precise dose targeting for body composition or performance goals
- Patients whose primary reason for considering pellets is “less hassle” rather than a specific clinical need
Before you book.
Do you offer pellet therapy?
Yes — when it’s the right fit for a specific patient. For most patients new to hormone therapy or with monitoring-intensive situations, we typically recommend adjustable delivery methods (weekly testosterone injection for men; transdermal estradiol with oral progesterone for women) as the starting point. Some patients have a clear case for pellets from the outset, and we offer them in those situations.
How do BioTE, EvexiPEL, and SottoPelle compare?
These are the major branded pellet systems with established prescriber training programs. The underlying technology is similar — compressed bioidentical testosterone (with or without estradiol) for subcutaneous placement. The differences are primarily in branding, prescriber training, and specific dosing protocols. The core clinical considerations apply to all of them. None of them have published outcomes data showing meaningful superiority over FDA-approved adjustable delivery methods.
Are pellets “more bioidentical” than other forms of hormone therapy?
No. “Bioidentical” describes the molecule, not the delivery method. The estradiol in an FDA-approved transdermal patch and the estradiol in a compounded pellet are chemically identical. The same applies to testosterone in injection form vs. pellet form. Both are bioidentical hormone replacement. The difference is in delivery mechanism, dose precision, and ability to adjust — not bioidenticity. See our bioidenticals page for more.
What does the Endocrine Society say about pellets?
The Endocrine Society’s clinical practice guideline on testosterone therapy in men does not list pellets among preferred delivery methods, citing concerns about the inability to discontinue rapidly if needed. The Menopause Society has expressed similar concerns about compounded pellet therapy for menopausal hormone treatment. Both societies generally favor FDA-approved alternatives. That said, professional society guidance reflects general patterns — individual patient decisions are made case-by-case based on the specific clinical situation.
I’ve had pellets at another clinic. Can I transition to a different delivery method with you?
Yes — and we do this transition regularly. The timing matters: we typically don’t start an adjustable protocol until the current pellet has substantially absorbed, to avoid stacking effects. We run baseline labs, plan the timing together, and start the new protocol at a conservative dose with frequent monitoring. Most patients reach steady state within 8–12 weeks.
I’ve had pellets at another clinic and want to continue. Can I do that with you?
Yes, if the clinical picture supports continued pellet therapy. We’ll review your history, run our standard hormone panel, and either continue your pellet protocol or have an honest conversation about whether a delivery change makes sense. We don’t pressure patients off pellets when they’re working — but we do reassess fit periodically.
How much do pellets cost vs. other approaches?
Pellet placement typically runs $400–$800 per insertion for men, $300–$600 for women, every 3–6 months. Over a year, that’s typically $1,200–$2,400 in procedure fees. FDA-approved testosterone cypionate (men) is typically $30–$80/month with most insurance covering it. FDA-approved transdermal estradiol (women) is typically $20–$60/month. Our clinical service fees cover physician oversight and monitoring separately. Cost is usually somewhat higher for pellets over a year — but for some patients that tradeoff is worth it for the placement frequency.
Let’s talk it through.
A 45-minute consultation with one of our Houston physicians. Whether you’re considering pellets for the first time, transitioning from another clinic, or weighing pellets against other delivery methods — we’ll walk through the decision together.